Dilmapimod Completed Phase 1 Trials for Rheumatoid Arthritis / Inflammatory Reaction Diagnostic

IndicationsStatusPurposePhase
CompletedDiagnostic1
clinicaltrials.gov IdentifierTitleDrugs
NCT00439881A Study To Look At The Safety Of SB-681323 In Healthy Adult Subjects After Intravenous Administration Of A Single Dose